Over 90% of patients with severely damaged corneas responded to the treatment in an early clinical trial.
Groundbreaking Stem Cell Therapy Repairs Badly Damaged Corneas and Improves Sight
Related Posts
McDonald’s is ending a two-year-old partnership with IBM to test…